The androgen receptor remains a key player in metastatic hormone-refractory prostate cancer. Implications for new treatments. [electronic resource]
- Journal of B.U.ON. : official journal of the Balkan Union of Oncology
- 357-64 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review